ReproNovo News and Activities

View the org chart displaying its 13 main executives

Most searched biographies at ReproNovo

• Jean Marie Duvall, Chief Executive Officer
• Ksenija Pavletic, Director
• Zina Affas Besse, Director

Popular executive movements at ReproNovo

• Mark Altmeyer has joined the company as Chairman of the Board  (posted on March 23 2026).

Create your alert
to follow the executive moves at ReproNovo.

ReproNovo has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by ReproNovo

• REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD - ReproNovo
• News Archive - ReproNovo
• REPRONOVO ANNOUNCES CLINICAL TRIAL APPROVAL NOTICE FOR RPN-001 IN CHINA - ReproNovo
• REPRONOVO RAISES $65 MILLION SERIES A FINANCING TO ADVANCE PHASE 2 CLINICAL TRIALS OF NOVEL THERAPIES IN REPRODUCTIVE MEDICINE AND WOMEN’S HEALTH - ReproNovo
• REPRONOVO ANNOUNCES FIRST PARTICIPANT INCLUDED IN U.S. PHASE 2 TRIAL OF RPN-001 FOR MALE INFERTILITY - ReproNovo

Social media about ReproNovo

• ReproNovo on Wikipedia, Google News & Yahoo Finance
• ReproNovo on LinkedIn, X (Twitter) & YouTube